Schedule 13G ownership disclosure

Corbus Pharmaceuticals Holdings, Inc.

Security class unavailable · CUSIP: 21833P103

Event date: 2020-08-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,771,557
Percent of class
4.6200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-20-020809
Form type
SC 13G/A
Filer
Corbus Pharmaceuticals Holdings, Inc.
CIK
CIK 1595097
Filed
Aug 07, 2020
Reporting period
Aug 06, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub